Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 2305-2307, June 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Speck, W. T.
Right arrow Articles by Rosenkranz, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Speck, W. T.
Right arrow Articles by Rosenkranz, H. S.

Effect of Genotype on Mutagenicity of Niridazole in Nitroreductase-deficient Bacteria1

William T. Speck2, Jeffrey L. Blumer, E. Joshua Rosenkranz and Herbert S. Rosenkranz

Department of Pediatrics [W. T. S., J. L. B.], The Genetics Center [J. L. B.], and the Department of Pharmacology [J. L. B.], Case Western Reserve University, Cleveland, Ohio 44106, and Department of Microbiology [E. J. R., H. S. R.], New York Medical College, Valhalla, New York 10595

The mutagenicity of niridazole for Salmonella typhimurium depends upon the enzymic reduction of the nitro function. The response of niridazole nitroreductase-deficient bacteria to niridazole is reduced to 4.4 and 0.19% that exhibited by the enzyme-proficient parent strain when the deficiency is the result of a base substitution and frame-shift mutation, respectively. The results are taken to indicate that the residual activity (4.4%) seen in the strain with a base substitution mutation reflects the activity of an enzyme with an amino acid substitution, while the basal level (0.19%) of activity indicates the action of a different nitroreductase with a low specificity for niridazole.

1 This investigation was supported by the National Cancer Institute.

2 Recipient of National Cancer Institute Research Career Development Award 1 KO4 CA 0043-01. To whom requests for reprints should be addressed, at Department of Pediatrics, Case Western Reserve University, 2101 Adelbert Road, Cleveland, Ohio 44106.

Received 11/21/80. Accepted 3/10/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.